RXRX

RECURSION PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.36

EPS Forecast

$14.46

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
BEAMBeam Therapeutics IncIBRXImmunitybio IncALECAlector IncKYMRKymera Therapeutics IncFATEFate Therapeutics IncALLOAllogene Therapeutics Inc